skip to main content
Language:
Search Limited to: Search Limited to: Resource type Show Results with: Show Results with: Search type Index

Results 1 - 20 of 135  for All Library Resources

Results 1 2 3 4 5 next page
Result Number Material Type Add to My Shelf Action Record Details and Options
1
Clinicopathological and molecular differences between right-sided and left-sided colorectal cancer in Japanese patients
Material Type:
Article
Add to My Research

Clinicopathological and molecular differences between right-sided and left-sided colorectal cancer in Japanese patients

Japanese journal of clinical oncology, 2018-07, Vol.48 (7), p.609-618 [Peer Reviewed Journal]

The Author(s) 2018. Published by Oxford University Press. All rights reserved. For permissions, please e-mail: journals.permissions@oup.com. 2018 ;ISSN: 1465-3621 ;EISSN: 1465-3621 ;DOI: 10.1093/jjco/hyy069 ;PMID: 29767751

Full text available

2
Efficacy and safety of abiraterone acetate plus prednisone in Japanese patients with newly diagnosed, metastatic hormone-naïve prostate cancer: a subgroup analysis of LATITUDE, a randomized, double-blind, placebo-controlled, Phase 3 study
Material Type:
Article
Add to My Research

Efficacy and safety of abiraterone acetate plus prednisone in Japanese patients with newly diagnosed, metastatic hormone-naïve prostate cancer: a subgroup analysis of LATITUDE, a randomized, double-blind, placebo-controlled, Phase 3 study

Japanese journal of clinical oncology, 2018-11, Vol.48 (11), p.1012-1021 [Peer Reviewed Journal]

The Author(s) 2018. Published by Oxford University Press. All rights reserved. For permissions, please e-mail: journals.permissions@oup.com. 2018 ;The Author(s) 2018. Published by Oxford University Press. 2018 ;ISSN: 1465-3621 ;ISSN: 0368-2811 ;EISSN: 1465-3621 ;DOI: 10.1093/jjco/hyy129 ;PMID: 30371895

Full text available

3
A competing-risks nomogram for predicting probability of death from CRC in Chinese Han patients with Stage I-III CRC
Material Type:
Article
Add to My Research

A competing-risks nomogram for predicting probability of death from CRC in Chinese Han patients with Stage I-III CRC

Japanese journal of clinical oncology, 2018-12, Vol.48 (12), p.1088-1095 [Peer Reviewed Journal]

ISSN: 1465-3621 ;EISSN: 1465-3621 ;DOI: 10.1093/jjco/hyy136 ;PMID: 30257010

Full text available

4
Phase 3 study of ceritinib vs chemotherapy in ALK-rearranged NSCLC patients previously treated with chemotherapy and crizotinib (ASCEND-5): Japanese subset
Material Type:
Article
Add to My Research

Phase 3 study of ceritinib vs chemotherapy in ALK-rearranged NSCLC patients previously treated with chemotherapy and crizotinib (ASCEND-5): Japanese subset

Japanese journal of clinical oncology, 2018-04, Vol.48 (4), p.367-375 [Peer Reviewed Journal]

The Author(s) 2018. Published by Oxford University Press. 2018 ;ISSN: 1465-3621 ;ISSN: 0368-2811 ;EISSN: 1465-3621 ;DOI: 10.1093/jjco/hyy016 ;PMID: 29474558

Full text available

5
A multicenter Phase II study of sorafenib in Japanese patients with advanced hepatocellular carcinoma and Child Pugh A and B class
Material Type:
Article
Add to My Research

A multicenter Phase II study of sorafenib in Japanese patients with advanced hepatocellular carcinoma and Child Pugh A and B class

Japanese journal of clinical oncology, 2018-04, Vol.48 (4), p.317-321 [Peer Reviewed Journal]

ISSN: 1465-3621 ;EISSN: 1465-3621 ;DOI: 10.1093/jjco/hyy010 ;PMID: 29474553

Full text available

6
Loss of CD15 expression in clear cell renal cell carcinoma is correlated with worse prognosis in Chinese patients
Material Type:
Article
Add to My Research

Loss of CD15 expression in clear cell renal cell carcinoma is correlated with worse prognosis in Chinese patients

Japanese journal of clinical oncology, 2017-12, Vol.47 (12), p.1182-1188 [Peer Reviewed Journal]

The Author 2017. Published by Oxford University Press. All rights reserved. For permissions, please e-mail: journals.permissions@oup.com. ;ISSN: 0368-2811 ;EISSN: 1465-3621 ;DOI: 10.1093/jjco/hyx139 ;PMID: 29036563

Full text available

7
Prevalence and molecular characteristics of defective mismatch repair epithelial ovarian cancer in a Japanese hospital-based population
Material Type:
Article
Add to My Research

Prevalence and molecular characteristics of defective mismatch repair epithelial ovarian cancer in a Japanese hospital-based population

Japanese journal of clinical oncology, 2018-08, Vol.48 (8), p.728-735 [Peer Reviewed Journal]

ISSN: 1465-3621 ;EISSN: 1465-3621 ;DOI: 10.1093/jjco/hyy081 ;PMID: 29889250

Full text available

8
First-line bevacizumab plus paclitaxel in Japanese patients with HER2-negative metastatic breast cancer: subgroup results from the randomized Phase III MERiDiAN trial
Material Type:
Article
Add to My Research

First-line bevacizumab plus paclitaxel in Japanese patients with HER2-negative metastatic breast cancer: subgroup results from the randomized Phase III MERiDiAN trial

Japanese journal of clinical oncology, 2017-05, Vol.47 (5), p.385-392 [Peer Reviewed Journal]

The Author 2017. Published by Oxford University Press. All rights reserved. For Permissions, please email: journals.permissions@oup.com. ;ISSN: 0368-2811 ;EISSN: 1465-3621 ;DOI: 10.1093/jjco/hyx001 ;PMID: 28158579

Full text available

9
Ceritinib in patients with advanced, crizotinib-treated, anaplastic lymphoma kinase-rearranged NSCLC: Japanese subset
Material Type:
Article
Add to My Research

Ceritinib in patients with advanced, crizotinib-treated, anaplastic lymphoma kinase-rearranged NSCLC: Japanese subset

Japanese journal of clinical oncology, 2017-07, Vol.47 (7), p.618-624 [Peer Reviewed Journal]

The Author 2017. Published by Oxford University Press. All rights reserved. For permissions, please e-mail: journals.permissions@oup.com. ;ISSN: 0368-2811 ;EISSN: 1465-3621 ;DOI: 10.1093/jjco/hyx045 ;PMID: 28369553

Full text available

10
Phase 1 study of ombrabulin in combination with docetaxel and cisplatin in Japanese patients with advanced solid tumors
Material Type:
Article
Add to My Research

Phase 1 study of ombrabulin in combination with docetaxel and cisplatin in Japanese patients with advanced solid tumors

Japanese journal of clinical oncology, 2018-04, Vol.48 (4), p.322-328 [Peer Reviewed Journal]

ISSN: 1465-3621 ;EISSN: 1465-3621 ;DOI: 10.1093/jjco/hyy026 ;PMID: 29514256

Full text available

11
Trends in the quality assurance process indicators for Japanese colorectal cancer screening during 2003–13
Material Type:
Article
Add to My Research

Trends in the quality assurance process indicators for Japanese colorectal cancer screening during 2003–13

Japanese journal of clinical oncology, 2018-04, Vol.48 (4), p.329-334 [Peer Reviewed Journal]

The Author(s) 2018. Published by Oxford University Press. All rights reserved. For permissions, please e-mail: journals.permissions@oup.com 2018 ;ISSN: 1465-3621 ;EISSN: 1465-3621 ;DOI: 10.1093/jjco/hyy022 ;PMID: 29506049

Full text available

12
Safety, efficacy and pharmacokinetics of humanized anti-CD52 monoclonal antibody alemtuzumab in Japanese patients with relapsed or refractory B-cell chronic lymphocytic leukemia
Material Type:
Article
Add to My Research

Safety, efficacy and pharmacokinetics of humanized anti-CD52 monoclonal antibody alemtuzumab in Japanese patients with relapsed or refractory B-cell chronic lymphocytic leukemia

Japanese journal of clinical oncology, 2017-01, Vol.47 (1), p.54-60 [Peer Reviewed Journal]

The Author 2016. Published by Oxford University Press. All rights reserved. For Permissions, please email: journals.permissions@oup.com. ;ISSN: 0368-2811 ;EISSN: 1465-3621 ;DOI: 10.1093/jjco/hyw146 ;PMID: 28122892

Full text available

13
Efficacy and safety of sequential use of everolimus in Japanese patients with advanced renal cell carcinoma after failure of first-line treatment with vascular endothelial growth factor receptor tyrosine kinase inhibitor: a multicenter phase II clinical trial
Material Type:
Article
Add to My Research

Efficacy and safety of sequential use of everolimus in Japanese patients with advanced renal cell carcinoma after failure of first-line treatment with vascular endothelial growth factor receptor tyrosine kinase inhibitor: a multicenter phase II clinical trial

Japanese journal of clinical oncology, 2017-06, Vol.47 (6), p.551-559 [Peer Reviewed Journal]

The Author 2017. Published by Oxford University Press. ;The Author 2017. Published by Oxford University Press. 2017 ;ISSN: 0368-2811 ;EISSN: 1465-3621 ;DOI: 10.1093/jjco/hyw194 ;PMID: 28334974

Full text available

14
An updated report on the trends in cancer incidence and mortality in Japan, 1958-2013
Material Type:
Article
Add to My Research

An updated report on the trends in cancer incidence and mortality in Japan, 1958-2013

Japanese journal of clinical oncology, 2015-04, Vol.45 (4), p.390-401 [Peer Reviewed Journal]

The Author 2015. Published by Oxford University Press. All rights reserved. For Permissions, please email: journals.permissions@oup.com. ;ISSN: 0368-2811 ;EISSN: 1465-3621 ;DOI: 10.1093/jjco/hyv002 ;PMID: 25637502

Full text available

15
Comparison of clinical features between suspected familial colorectal cancer type X and Lynch syndrome in Japanese patients with colorectal cancer: a cross-sectional study conducted by the Japanese Society for Cancer of the Colon and Rectum
Material Type:
Article
Add to My Research

Comparison of clinical features between suspected familial colorectal cancer type X and Lynch syndrome in Japanese patients with colorectal cancer: a cross-sectional study conducted by the Japanese Society for Cancer of the Colon and Rectum

Japanese journal of clinical oncology, 2015-02, Vol.45 (2), p.153-159 [Peer Reviewed Journal]

The Author 2014. Published by Oxford University Press. All rights reserved. For Permissions, please email: journals.permissions@oup.com. ;ISSN: 0368-2811 ;EISSN: 1465-3621 ;DOI: 10.1093/jjco/hyu190 ;PMID: 25404568

Full text available

16
Safety and efficacy of tumour-treating fields (TTFields) therapy for newly diagnosed glioblastoma in Japanese patients using the Novo-TTF System: a prospective post-approval study
Material Type:
Article
Add to My Research

Safety and efficacy of tumour-treating fields (TTFields) therapy for newly diagnosed glioblastoma in Japanese patients using the Novo-TTF System: a prospective post-approval study

Japanese journal of clinical oncology, 2023-04, Vol.53 (5), p.371-377 [Peer Reviewed Journal]

The Author(s) 2023. Published by Oxford University Press. 2023 ;The Author(s) 2023. Published by Oxford University Press. ;ISSN: 1465-3621 ;ISSN: 0368-2811 ;EISSN: 1465-3621 ;DOI: 10.1093/jjco/hyad001 ;PMID: 36647599

Full text available

17
Cancer Incidence and Incidence Rates in Japan in 2006: Based on Data from 15 Population-based Cancer Registries in the Monitoring of Cancer Incidence in Japan (MCIJ) Project
Material Type:
Article
Add to My Research

Cancer Incidence and Incidence Rates in Japan in 2006: Based on Data from 15 Population-based Cancer Registries in the Monitoring of Cancer Incidence in Japan (MCIJ) Project

Japanese journal of clinical oncology, 2012-02, Vol.42 (2), p.139-147 [Peer Reviewed Journal]

The Author 2011. Published by Oxford University Press. All rights reserved. For Permissions, please email: journals.permissions@oup.com 2011 ;ISSN: 0368-2811 ;EISSN: 1465-3621 ;DOI: 10.1093/jjco/hyr184 ;PMID: 22172347

Full text available

18
The safety profile of nivolumab plus ipilimumab combination therapy in Japanese patients with renal cell carcinoma: results from post-marketing surveillance
Material Type:
Article
Add to My Research

The safety profile of nivolumab plus ipilimumab combination therapy in Japanese patients with renal cell carcinoma: results from post-marketing surveillance

Japanese journal of clinical oncology, 2023-07, Vol.53 (8), p.730-737 [Peer Reviewed Journal]

The Author(s) 2023. Published by Oxford University Press. All rights reserved. For permissions, please e-mail: journals.permission@oup.com. 2023 ;The Author(s) 2023. Published by Oxford University Press. All rights reserved. For permissions, please e-mail: journals.permission@oup.com. ;ISSN: 1465-3621 ;ISSN: 0368-2811 ;EISSN: 1465-3621 ;DOI: 10.1093/jjco/hyad034 ;PMID: 37151051

Full text available

19
The Japanese Guidelines for Breast Cancer Screening
Material Type:
Article
Add to My Research

The Japanese Guidelines for Breast Cancer Screening

Japanese journal of clinical oncology, 2016-05, Vol.46 (5), p.482-492 [Peer Reviewed Journal]

The Author 2016. Published by Oxford University Press. All rights reserved. For Permissions, please email: journals.permissions@oup.com. ;ISSN: 0368-2811 ;EISSN: 1465-3621 ;DOI: 10.1093/jjco/hyw008 ;PMID: 27207993

Full text available

20
An updated report of the trends in cancer incidence and mortality in Japan
Material Type:
Article
Add to My Research

An updated report of the trends in cancer incidence and mortality in Japan

Japanese journal of clinical oncology, 2013-05, Vol.43 (5), p.492-507 [Peer Reviewed Journal]

ISSN: 0368-2811 ;EISSN: 1465-3621 ;DOI: 10.1093/jjco/hyt038 ;PMID: 23493744

Full text available

Results 1 - 20 of 135  for All Library Resources

Results 1 2 3 4 5 next page

Searching Remote Databases, Please Wait